Overview

Study Designed to Optimize the Treatment of Primary Pneumothorax

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.
Phase:
Early Phase 1
Details
Lead Sponsor:
Odense University Hospital
Collaborators:
Danish Medical Association
Danmarks Lungeforening